Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Advantage ITC - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Sep 15, 2000

    Advantage ITC

    The tobacco industry continues to be in the docks. Punitive taxation, ban on sale and /or smoking on railway premises or other such public places has taken the wind out of cigarette manufacturers. Ban imposed in states like Kerala and Goa has further added to their vows. As a result volumes declined by 5-6% in FY2000. The scenario is unlikely to change the next year too.

    Both the tobacco majors in India, ITC and Godfrey Phillips felt the pressure on their margins in FY2000. Though ITC managed to hold on and in fact produced more cigarette sticks (from 52.1 bn sticks in FY99 to 56.4 bn in FY00), Godfrey Philips saw a 19% decline in cigarette production to 5.7 bn sticks.

    FY2000 (Rs m) ITC Godfrey Godfrey/
    Sales 79,531 10,826 13.6%
    Other Income 1,699 115 6.7%
    Expenditure 66,093 10,222 15.5%
    Operating Profit (EBDIT) 13,437 604 4.5%
    Operating Profit Margin (%) 16.9% 5.6%  
    Interest 1,661 25 1.5%
    Depreciation 1,185 55 4.6%
    Profit before Tax 12,290 639 5.2%
    Tax 4,365 220 5.0%
    Profit after Tax/(Loss) 7,925 419 5.3%
    Net profit margin (%) 10.0% 3.9%  
    No. of Shares (eoy) (m) 245.4 10.4  
    Earnings per share 32.3 40.3  

    Both companies’ margins were under pressure in FY2000. But here too ITC’s margins (10%) were much better compared to Godfrey (4%). This is not only because ITC dominates this 97 bn cigarette sticks market with a 70% share but also because over the years it has spread its risks by entering other businesses.

    ITC operates in five principal businesses, namely, tobacco and cigarettes, hotels, paper and packaging, software and international trading. It is the industry leader in its core business of cigarette manufacturing and tobacco leaf procurement, processing and exports in India. It is also one of India’s largest foreign exchange earners. Whereas Godfrey’s lone diversification is into packaged tea. The tea business is itself under a lot of pressure due to decline in prices.

    So the diversification has in fact come as a boon for ITC, which is likely to show sustained growth despite adverse business conditions in its core business of cigarettes and tobacco. The same cannot be said for Godfrey Phillips.

    On the back of all this, the markets have treated ITC better than Godfrey. While ITC trades at Rs 825, a P/e ratio of 27 times its FY2000 earnings, the Godfrey stock trades at Rs 407, a P/e ratio of 10 times. While ITC is down only 20% compared to its 52 week peak, Godfrey is down a whopping 56% from its 52 week peak.



    Equitymaster requests your view! Post a comment on "Advantage ITC". Click here!


    More Views on News

    GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

    Jun 20, 2017

    While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

    ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

    Feb 8, 2017

    ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

    ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

    Dec 7, 2016

    ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

    ITC: Numbers Go Nowhere in FY16... (Quarterly Results Update - Detailed)

    Jun 8, 2016

    ITC declared results for the quarter and year ended March 2016. During the year, the company's net revenues and profits rise by 1% YoY and 3% YoY respectively.

    GSK Consumer: A Forgetful Year (Quarterly Results Update - Detailed)

    Jun 1, 2016

    GSK Consumer Healthcare announced its results for the quarter and year ended March 2016. During the quarter, sales and profit came in lower by 9% YoY and 8% YoY respectively.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms